EFMH
GMAB icon

E Fund Management (HK)’s Genmab GMAB Stock Holding History

E Fund Management (HK)’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6K Buy
713
+180
+34% +$4.78K 0.01% 319
2026
Q1 		$14.3K Buy
+533
New +$16K 0.01% 272

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

E Fund Management (HK)'s GMAB Position: Q2 2026 in Review

E Fund Management (HK) increased its Genmab (GMAB) stake by 34% in Q2 2026, buying an estimated $4.78K and bringing the position to 713 shares worth $19.6K. The position accounts for 0.01% of the portfolio, ranked #319.

E Fund Management (HK) first reported a position in GMAB in Q1 2026 and has held it in 2 quarters since. 290 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • E Fund Management (HK) held 713 shares of Genmab worth $19.6K as of Q2 2026.
  • E Fund Management (HK) bought 180 Genmab shares in Q2 2026, an estimated $4.78K.
  • Genmab made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #319 holding.
  • E Fund Management (HK) first reported a position in Genmab in Q1 2026 and has held it in 2 quarters since.
  • 290 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.